Application | Comment | Organism |
---|---|---|
medicine | copper and zinc complexes of terpyridine derivatives are stable under various conditions and are not expected to pose delivery problems, qualities vital for the development of a wide-scope anti-bioterror agent for civil and military uses | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Cu(2,2':6,2''-terpyridine)Cl2 | IC50: 0.0077 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | |
Cu(4'-hydroxo-2,2':6',2''-terpyridine)Cl2 | IC50: 0.0072 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | |
Cu(4'-[4-methoxyphenyl]-2,2':6',2''-terpyridine)Cl2 | IC50: 0.0051 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | |
Cu(4'-[p-tolyl]-2,2':6',2''-terpyridine)Cl2 | 0.005 mM | Homo sapiens | |
Cu(4,4''-dimethyl-4'-[p-tolyl]-2,2':6',2''-terpyridine)Cl2 | IC50: 0.014 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | |
Cu(di-[2-picolyl]amine)Cl2 | IC50: 0.038 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | |
Cu2+ | IC50: 0.014 mM | Homo sapiens | |
Zn(4'-[4-methoxyphenyl]-2,2':6',2''-terpyridine)Cl2 | IC50: 0.009 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | |
Zn(4'-[p-tolyl]-2,2':6',2''-terpyridine)Cl2 | IC50: 0.009 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | |
Zn(4,4''-dimethyl-4'-[p-tolyl]-2,2':6',2''-terpyridine)Cl2 | 0.014 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | |
Zn2+ | IC50: 0.021 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | |
[Cu(2,2':6,2''-terpyridine)Cl2] (OCl4) | IC50: 0.0069 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide + H2O | - |
Homo sapiens | tert-butyloxycarbonyl-Arg-Val-Arg-Arg + 7-amino-4-methylcoumarin | - |
? |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0051 | - |
IC50: 0.0051 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | Cu(4'-[4-methoxyphenyl]-2,2':6',2''-terpyridine)Cl2 | |
0.0069 | - |
IC50: 0.0069 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | [Cu(2,2':6,2''-terpyridine)Cl2] (OCl4) | |
0.0072 | - |
IC50: 0.0072 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | Cu(4'-hydroxo-2,2':6',2''-terpyridine)Cl2 | |
0.0077 | - |
IC50: 0.0077 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | Cu(2,2':6,2''-terpyridine)Cl2 | |
0.009 | - |
IC50: 0.009 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | Zn(4'-[4-methoxyphenyl]-2,2':6',2''-terpyridine)Cl2 | |
0.009 | - |
IC50: 0.009 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | Zn(4'-[p-tolyl]-2,2':6',2''-terpyridine)Cl2 | |
0.014 | - |
IC50: 0.014 mM | Homo sapiens | Cu2+ | |
0.014 | - |
IC50: 0.014 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | Cu(4,4''-dimethyl-4'-[p-tolyl]-2,2':6',2''-terpyridine)Cl2 | |
0.021 | - |
IC50: 0.021 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | Zn2+ | |
0.038 | - |
IC50: 0.038 mM, irreversible, competitive with substrate tert-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide | Homo sapiens | Cu(di-[2-picolyl]amine)Cl2 |